Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis
about
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human DataDeficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in miceBile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasisPathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.The impact of insulin treatment on the expression of vascular endothelial cadherin and Beta-catenin in human fetoplacental vessels.Induction of experimental obstructive cholestasis in mice.The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury.Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.Evaluation of Histological and non-Invasive Methods for the Detection of Liver Fibrosis: The Values of Histological and Digital Morphometric Analysis, Liver Stiffness Measurement and APRI Score.Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosisThe impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children.Statins improve NASH via inhibition of RhoA and Ras.Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension.
P2860
Q30000071-B0168463-0FC7-41CD-B60E-7A4963DC77ABQ34545684-CF026342-78EF-4461-B177-6D057FDA9607Q35162240-E2D1D039-AF56-4A3A-AA1C-2C4416276203Q35847494-350F278A-699C-4BC9-84D2-F3DA634C7F93Q38831994-0708E432-25F9-4A56-A4C7-4C0C313C018FQ39105053-93F0790B-F71D-495D-AB9A-0E89D53DC635Q39191568-22486968-426A-490F-A709-AFA7FC83FFB9Q39647330-A04A3208-8D3D-4360-A5B9-60904849DE5DQ40210745-24E521BB-776D-49EE-B2BB-3BA1C238DCF2Q40297774-3B0FAE3A-72EB-4FBC-BAB3-29C364BDA1C4Q41029212-49951237-7621-4D12-B045-0852B456016CQ41870298-849E8C14-AFE0-4B12-A641-F41D5D4940C3Q44595693-2AA8A7DF-E465-4F8C-96A7-86EAF203E24CQ45896181-788E3268-9D86-4E49-9A8E-B1B85AAFF38BQ48352117-983DBA9B-8E61-4645-8A33-539421E0DCDBQ50533517-5F437C0A-2E96-4D45-9661-747FA42CB8FFQ54346025-92CFD86E-EEAE-4E43-9BAD-9C6C061C2BA8
P2860
Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development and evaluation of ...... antification of liver fibrosis
@en
Development and evaluation of ...... antification of liver fibrosis
@nl
type
label
Development and evaluation of ...... antification of liver fibrosis
@en
Development and evaluation of ...... antification of liver fibrosis
@nl
prefLabel
Development and evaluation of ...... antification of liver fibrosis
@en
Development and evaluation of ...... antification of liver fibrosis
@nl
P2093
P2860
P356
P1476
Development and evaluation of ...... antification of liver fibrosis
@en
P2093
Diane Goltz
Hans-Peter Fischer
Jörg Schmitz
Reinhard Büttner
Sebastian Huss
P2860
P2888
P356
10.1186/1755-1536-3-10
P577
2010-06-17T00:00:00Z
P5875
P6179
1037202256